{"meta":{"query_hash":"fd29516cb3ef","filters":{"venue":"IJU Case Reports"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/fd29516cb3ef","api":"https://metacan.xera.ac/api/v1/cohort?venue=IJU+Case+Reports"},"results":[{"id":"W2911614647","doi":"10.1002/iju5.12047","title":"Renal transplant anastomotic pseudoaneurysms: Case report of open repair and endovascular management","year":2019,"lang":"en","type":"article","venue":"IJU Case Reports","topic":"Renal and Vascular Pathologies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Medicine; Pseudoaneurysm; Surgery; Anastomosis; Angioplasty; External iliac artery; Renal artery; Stent; Vascularity; Radiology; Aneurysm; Kidney; Internal medicine","score_opus":0.019739539906730105,"score_gpt":0.2780781752661,"score_spread":0.2583386353593699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2911614647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658328,0.014177669,0.0065345685,0.003350461,0.00075272185,0.00024936305,0.00021853812,0.00025483457,0.008628958],"genre_scores_gemma":[0.99137974,0.0028938833,0.001972753,0.0007037497,0.0016621826,0.000046204754,0.00010223656,0.000029094212,0.001210025],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987362,0.00013233499,0.00017770297,0.00024309836,0.00020424367,0.00050641363],"domain_scores_gemma":[0.99722844,0.0005876559,0.0008657226,0.00029468638,0.00012934886,0.00089416845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005956264,0.002451886,0.0014277337,0.0037491056,0.003109236,0.0032760485,0.0018482264,0.0073161125,0.002703943],"category_scores_gemma":[0.003989462,0.0016975123,0.0015484868,0.0021148953,0.002220711,0.0028606837,0.002628332,0.004159405,0.0011983018],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016501039,0.00005493239,0.004417799,0.000023280743,0.000011229962,0.9939434,0.00011954843,0.000037960195,0.00023638757,0.00010920715,0.00015640187,0.0008734301],"study_design_scores_gemma":[0.000004446596,0.00001537835,0.0015186748,0.000006739056,0.0000045962543,0.9979976,0.00006665121,0.000049370778,0.00008654757,0.00005685425,0.00018747998,0.000005596387],"about_ca_topic_score_codex":0.0010721873,"about_ca_topic_score_gemma":0.0014472784,"teacher_disagreement_score":0.0073161125,"about_ca_system_score_codex":0.0011354571,"about_ca_system_score_gemma":0.0012001415,"threshold_uncertainty_score":0.009045541},"labels":[],"label_agreement":null},{"id":"W3047015683","doi":"10.1002/iju5.12208","title":"Successful treatment of recurrent small cell carcinoma of urinary bladder with pembrolizumab","year":2020,"lang":"en","type":"article","venue":"IJU Case Reports","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Cystectomy; Medicine; Urinary bladder; Pembrolizumab; Etoposide; Urology; Carcinoma; Small-cell carcinoma; Cisplatin; Chemotherapy; Pathology; Oncology; Internal medicine; Bladder cancer; Immunotherapy; Cancer","score_opus":0.0361745194726544,"score_gpt":0.2979567915051543,"score_spread":0.26178227203249993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047015683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541289,0.017993378,0.0136774145,0.0047136005,0.00090960367,0.0004674246,0.0002925113,0.0005585006,0.00725874],"genre_scores_gemma":[0.98987496,0.0031462715,0.002409857,0.001034246,0.00036458528,0.0000903179,0.00028398726,0.000032782053,0.0027629265],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9997992,0.000026876498,0.00002741553,0.000041213952,0.00003679374,0.00006851527],"domain_scores_gemma":[0.9997681,0.000037601436,0.00003822105,0.000041400886,0.000014515101,0.000100168516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022414842,0.00080195675,0.00081527163,0.0006345411,0.0007841352,0.00035157215,0.0007708718,0.0016998604,0.00077415287],"category_scores_gemma":[0.00086215377,0.00022991582,0.0011147844,0.0002766723,0.0004347382,0.00050584046,0.00050073565,0.0012572657,0.00038813104],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008586505,0.0005175481,0.011446097,0.00040307496,0.00017986582,0.8876459,0.00034010262,0.0012264566,0.018552061,0.00057544955,0.0020806766,0.07617413],"study_design_scores_gemma":[0.0003011362,0.0022525094,0.022504041,0.0001066763,0.00021324224,0.94460964,0.00011560029,0.0039766924,0.014547968,0.0006590297,0.010659881,0.0000536083],"about_ca_topic_score_codex":0.00088067964,"about_ca_topic_score_gemma":0.0016859021,"teacher_disagreement_score":0.0016998604,"about_ca_system_score_codex":0.00047268474,"about_ca_system_score_gemma":0.0005031264,"threshold_uncertainty_score":0.003429532},"labels":[],"label_agreement":null},{"id":"W4385781421","doi":"10.1002/iju5.12614","title":"Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era","year":2023,"lang":"en","type":"article","venue":"IJU Case Reports","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northern Alberta Institute of Technology; Alberta Cancer Foundation; University of Alberta Hospital; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; Prostatectomy; Positron emission tomography; Magnetic resonance imaging; Prostate; Biopsy; Radiology; Cancer; Glutamate carboxypeptidase II; Urology; Nuclear medicine; Internal medicine","score_opus":0.014917036286696824,"score_gpt":0.2654169570490042,"score_spread":0.25049992076230737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385781421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512234,0.015075813,0.0033297713,0.0022734955,0.00033309494,0.00013650472,0.0005722589,0.00027544986,0.026780346],"genre_scores_gemma":[0.99631387,0.0011398743,0.0006264596,0.00044722852,0.00020836096,0.0000066462762,0.00014257332,0.000015495467,0.0010995942],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9995915,0.000078597746,0.00003511336,0.00006703922,0.000094129035,0.00013356227],"domain_scores_gemma":[0.99925107,0.00018257344,0.00019665695,0.00006488176,0.000056763623,0.0002480175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002577758,0.00069526257,0.0005013807,0.0012969855,0.00074050634,0.00063979847,0.00088962977,0.0012935245,0.004073754],"category_scores_gemma":[0.0017863052,0.00039852542,0.00038636697,0.00096944947,0.0010451055,0.00088958483,0.0007793174,0.0010856118,0.000578958],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020375098,0.00007999377,0.09623917,0.00027346064,0.00008598497,0.8802557,0.00037532448,0.00022027732,0.006007165,0.00072665146,0.0020795031,0.013453025],"study_design_scores_gemma":[0.000008399927,0.00011978923,0.030370086,0.000041831943,0.000023827826,0.9654129,0.00016468929,0.00014070202,0.001080963,0.00039362325,0.0022249399,0.000018250936],"about_ca_topic_score_codex":0.0020178882,"about_ca_topic_score_gemma":0.0027799637,"teacher_disagreement_score":0.004073754,"about_ca_system_score_codex":0.00038312355,"about_ca_system_score_gemma":0.000517214,"threshold_uncertainty_score":0.013628125},"labels":[],"label_agreement":null}]}